APA (7th ed.) Citation

Camidge, D. R., & Bendszus, M. (2018). Clinical trial design for systemic agents in patients with brain metastases from solid tumours: A guideline by the response assessment in neuro-oncology brain metastases working group. The lancet. Oncology, 19(1), . https://doi.org/10.1016/S1470-2045(17)30693-9

Chicago Style (17th ed.) Citation

Camidge, David Ross, and Martin Bendszus. "Clinical Trial Design for Systemic Agents in Patients with Brain Metastases from Solid Tumours: A Guideline by the Response Assessment in Neuro-oncology Brain Metastases Working Group." The Lancet. Oncology 19, no. 1 (2018). https://doi.org/10.1016/S1470-2045(17)30693-9.

MLA (9th ed.) Citation

Camidge, David Ross, and Martin Bendszus. "Clinical Trial Design for Systemic Agents in Patients with Brain Metastases from Solid Tumours: A Guideline by the Response Assessment in Neuro-oncology Brain Metastases Working Group." The Lancet. Oncology, vol. 19, no. 1, 2018, https://doi.org/10.1016/S1470-2045(17)30693-9.